Abstract
Purpose: Determination of lymphatic spread is the most important prognostic factor in breast cancer. The concept of sentinel lymph node dissection was introduced to determine the status of the lymph nodes in axilla without dissection. We searched which technique is more effective and correct.
Materials and Methods: Vital dye, lymphoscintigraphy + intraoperative gamma probing; and combined techniques were performed randomized on 3 groups made of 20 patients. Patent blue violet was used as vital dye and 1 ml each was injected to 4 quadrants surrounding the tumor and also subdermally. Albumin marked with Tc 99m sulphur colloid total 1 ml(200 MBq) was used as isotope and injected to the 4 surrounding quadrants again. During operation intraoperative gamma probing was used in 2nd and 3rd groups. The lymph node that has a minimum 10 fold value from the background measurement was accepted as sentinel lymph node. The obtained lymph nodes analyzed using routine hematoxylin and eosin study and immunohistochemical study.
Results: In vital dye group, the rate of identification was 85% and false negative rate of 16,7%. The rates were 95%, 0% in lymphoscintigraphy + intraoperative gamma probing group and 100%, 0% in combined group, respectively.
Conclusions: We determined % 100 identification rate in combined group due to applicating 5 ml. blue dye to peritumorally + subdermally and applicating 1 ml. isotope to peritumorally. We propose to combine technique with this applicating road for sentinel lymph node biopsy.
Keywords:
Sentinel lymph node, lymphoscintigraphy, intraoperative gamma probe, breast cancer.
References
1Fisher ER, Gregorio RM, Fisher B. The pathology of invasive breast cancer. Cancer, 1975; 36: 1.
2Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast canser patients. J Clin Oncol, 1993; 11: 1536.
3Giuiliano AE, Kırgan DM, Guenther JM,et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 1994; 220: 391-401.
4The Ludwig Breast Cancer Study Group. Prolonged disease free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med, 1989; 320:491.
5Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Cancer, 1994; 73:664.
6Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol, 1993; 11:1536.
7International (Ludwig) Breast cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet, 1990; 335:1565-1568.
8Krag D, Weaver D, Alex J, et al. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gama probe. Surg Oncol, 1993; 2: 335-339.
9Giuiliano AE, Kırgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 1994; 220:391-401.
10De Cicco C, Cremonesi M, Luini A. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med, 1998; 12:2080-2084.
11Linehan DC, Hill Ad, Akhurst T. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol, 1999; 6:450-454.
12Flett MM, Going JJ, Stanton PD, et al. Sentinel node localization in patients with breast cancer. Br J Surg, 1998; 85:991.
13Horgan K, Mancie-Jones B, Madan M, et al. Axillary sentinel node identification in breast cancer with dye injection alone. Br J Surg,1998; 85:51.
14Crossin JA, Johnson AC, Stewart PB, et al. Gamma probe guided resection of the sentinel lymph node in breast cancer. Am Surg, 1998; 64:666.
15Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med, 1998; 339:941.
16Gill PG, Hall VE, Kirkwood I, et al. Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer. Breast, 1997; 6:225.
17Borgstein PJ, Pijpers R, Comans EF,et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg, 1998; 186:275.
18De Vries J, Doting MHE, Nieweg OE, et al. Combined detection technique of radioactive tracer and blue dye for sentinel lymph node biopsy in breast cancer. In 51st Annual Meeting of the Society of Surgical Oncology and the World Federation of Surgical Oncology Societies Congress;70, 1998.
19Van der Ent FWC, Kengen RAM, Van der Poll HAG, Hoofwijk AGM. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol,1999; 25:24.